CDNA vs COP · rev $333.8M vs P/E 19, rev $58.94B
CareDx Inc (CDNA) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported CDNA revenue for 2024-12-31 was $333.8M. Net income was $52.5M. Revenue was up 19.1% from 2023-12-31 to 2024-12-31. CDNA currently screens at market cap $1.18B.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
CDNA currently screens at market cap $1.18B. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the CDNA and COP stock pages for the full models.
Not investment advice.